BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16061866)

  • 1. XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
    Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E
    Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro.
    Zhou Q; Guo AL; Xu CR; An SJ; Wang Z; Yang SQ; Wu YL
    Clin Exp Immunol; 2008 Sep; 153(3):392-400. PubMed ID: 18803763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of XAGE-1b gene expression with clinical characteristics of non-small cell lung cancer].
    Zhou Q; Guo AL; An SJ; Xu CR; Yang SQ; Wu YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):966-8. PubMed ID: 17666327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma.
    Wang T; Fan L; Watanabe Y; McNeill P; Fanger GR; Persing DH; Reed SG
    Oncogene; 2001 Nov; 20(53):7699-709. PubMed ID: 11753648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.
    John T; Caballero OL; Svobodová SJ; Kong A; Chua R; Browning J; Fortunato S; Deb S; Hsu M; Gedye CA; Davis ID; Altorki N; Simpson AJ; Chen YT; Monk M; Cebon JS
    Clin Cancer Res; 2008 Jun; 14(11):3291-8. PubMed ID: 18519755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
    Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E
    Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
    Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
    Watanabe Y; LePage S; Elliott M; Secrist H; Tanaka T; Kawahara M; Matsumura A; Hosoe S; Ogawara M; Okada M; Repasky B; Sleath P; Wang T; Henderson R
    Cancer Immun; 2006 Feb; 6():3. PubMed ID: 16468707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
    Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E
    Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NY-ESO-1 expression and immunogenicity in esophageal cancer.
    Fujita S; Wada H; Jungbluth AA; Sato S; Nakata T; Noguchi Y; Doki Y; Yasui M; Sugita Y; Yasuda T; Yano M; Ono T; Chen YT; Higashiyama M; Gnjatic S; Old LJ; Nakayama E; Monden M
    Clin Cancer Res; 2004 Oct; 10(19):6551-8. PubMed ID: 15475443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers.
    Egland KA; Kumar V; Duray P; Pastan I
    Mol Cancer Ther; 2002 May; 1(7):441-50. PubMed ID: 12479262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
    Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
    Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CABYR is a novel cancer-testis antigen in lung cancer.
    Luo C; Xiao X; Liu D; Chen S; Li M; Xu A; Liu J; Gao S; Wu S; He D
    Clin Cancer Res; 2007 Feb; 13(4):1288-97. PubMed ID: 17317841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
    Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
    Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells.
    Shimono M; Uenaka A; Noguchi Y; Sato S; Okumura H; Nakagawa K; Kiura K; Tanimoto M; Nakayama E
    Int J Oncol; 2007 Apr; 30(4):835-40. PubMed ID: 17332921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors.
    Sato S; Noguchi Y; Ohara N; Uenaka A; Shimono M; Nakagawa K; Koizumi F; Ishida T; Yoshino T; Shiratori Y; Nakayama E
    Cancer Immun; 2007 Mar; 7():5. PubMed ID: 17335148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer.
    Pandey JP; Namboodiri AM; Ohue Y; Oka M; Nakayama E
    Clin Exp Immunol; 2014 Apr; 176(1):78-83. PubMed ID: 24304136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.